Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 17,243 shares at $27.00 ($466K) on 2019-09-06, disclosed to the SEC on 2019-09-09.
Open-market sale of $466k YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 11,452 | $309K | 66.4% |
| 2 | $27.00 | 5,791 | $156K | 33.6% |
| Total | $27.00 avg | 17,243 | $466K | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |